Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies.
Soulard M, Galicier L, Mahlaoui N, Fieschi C, Deshayes S, Gobert D, Gourguechon C, Henique H, Humbert S, Lacout C, Le Calloch R, Michel M, Piel-Julian ML, Viallard JF, Lescoat A, Godeau B, Perlat A.
Soulard M, et al. Among authors: perlat a.
Blood Adv. 2024 Dec 24;8(24):6171-6182. doi: 10.1182/bloodadvances.2024014370.
Blood Adv. 2024.
PMID: 39348667